{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:28:01Z","timestamp":1788834481883,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000291","name":"Kidney Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000291","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.trsl.2026.02.009","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T16:21:29Z","timestamp":1772036489000},"page":"17-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Exploring the role of chemerin in skeletal muscle phenotype in those with kidney disease"],"prefix":"10.1016","volume":"290","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2111-3832","authenticated-orcid":false,"given":"Luke A","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia RMJ","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela F","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Denniff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseanne E","family":"Billany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S","family":"March","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah ML","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Highton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew PM","family":"Graham-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert U","family":"Ashford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o L","family":"Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James O","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice C","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2026.02.009_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155379","article-title":"Adipose tissue adipokines and lipokines: functions and regulatory mechanism in skeletal muscle development and homeostasis","volume":"139","author":"Gu","year":"2023","journal-title":"Metab - Clin Exp"},{"key":"10.1016\/j.trsl.2026.02.009_bib0002","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11914-020-00599-y","article-title":"Bone, and fat crosstalk: the biological role of myokines, Osteokines, and adipokines","volume":"18","author":"Kirk","year":"2020","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.trsl.2026.02.009_bib0003","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gft191","article-title":"Adipokines promote chronic kidney disease","volume":"28","author":"Ruster","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2026.02.009_bib0004","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1681\/ASN.2006080916","article-title":"Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic Kidney disease: effects of Angiotensin II blockade","volume":"17","author":"de Vinuesa","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2026.02.009_bib0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cca.2019.08.028","article-title":"The cross-talk between adipokines and miRNAs in health and obesity-mediated diseases","volume":"499","author":"Ghasemi","year":"2019","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.trsl.2026.02.009_bib0006","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/abbs\/gmp091","article-title":"Proteolytic regulatory mechanism of chemerin bioactivity","volume":"41","author":"Du","year":"2009","journal-title":"Acta Biochim Biophys Sin"},{"key":"10.1016\/j.trsl.2026.02.009_bib0007","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.2337\/db09-0277","article-title":"Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary Human skeletal muscle cells","volume":"58","author":"Sell","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2026.02.009_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164179","article-title":"Signaling properties of Chemerin receptors CMKLR1, GPR1 and CCRL2","volume":"11","author":"De Henau","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.trsl.2026.02.009_bib0009","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00011-014-0792-7","article-title":"Chemerin\/chemR23 axis in inflammation onset and resolution","volume":"64","author":"Mariani","year":"2015","journal-title":"Inflamm Res"},{"key":"10.1016\/j.trsl.2026.02.009_bib0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/1110-7782.200964","article-title":"Serum chemerin level in chronic kidney disease","volume":"28","author":"Abd Rabo","year":"2016","journal-title":"Egypt J Intern Med"},{"key":"10.1016\/j.trsl.2026.02.009_bib0011","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.vph.2015.10.007","article-title":"Chemerin in renal dysfunction and cardiovascular disease","volume":"77","author":"Bonomini","year":"2016","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.trsl.2026.02.009_bib0012","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4103\/1319-2442.190867","article-title":"Chemerin: a biomarker for cardiovascular disease in diabetic chronic kidney disease patients","volume":"27","author":"Salama","year":"2016","journal-title":"Saudi J Kidney Dis Transplant"},{"key":"10.1016\/j.trsl.2026.02.009_bib0013","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1440-1797.2012.01572.x","article-title":"Oxidative stress, anti-oxidant therapies and chronic kidney disease: oxidative stress and CKD","volume":"17","author":"Small","year":"2012","journal-title":"Nephrology"},{"key":"10.1016\/j.trsl.2026.02.009_bib0014","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1093\/ndt\/gfq329","article-title":"Clinical importance of an elevated circulating chemerin level in incident dialysis patients","volume":"25","author":"Yamamoto","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2026.02.009_bib0015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2337\/dc09-1351","article-title":"Serum levels of the adipokine chemerin in relation to renal function","volume":"33","author":"Pfau","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trsl.2026.02.009_bib0016","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3109\/0886022X.2015.1040707","article-title":"High serum chemerin level in CKD patients is related to kidney function, but not to its adipose tissue overproduction","volume":"37","author":"Blaszak","year":"2015","journal-title":"Ren Fail"},{"key":"10.1016\/j.trsl.2026.02.009_bib0017","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/nep.13920","article-title":"Muscle power and physical dysfunction: a model for tailoring rehabilitation in chronic kidney disease","volume":"26","author":"Wilkinson","year":"2021","journal-title":"Nephrology"},{"key":"10.1016\/j.trsl.2026.02.009_bib0018","doi-asserted-by":"crossref","first-page":"1128S","DOI":"10.3945\/ajcn.2010.28608B","article-title":"Review of muscle wasting associated with chronic kidney disease","volume":"91","author":"Workeneh","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.trsl.2026.02.009_bib0019","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/ndt\/gfaa129","article-title":"Myostatin and muscle atrophy during chronic kidney disease","volume":"36","author":"Bataille","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2026.02.009_bib0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ndt\/gfz210","article-title":"Muscle mass and plasma myostatin after exercise training: a substudy of Renal Exercise (RENEXC)\u2014a randomized controlled trial","volume":"36","author":"Zhou","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2026.02.009_bib0021","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/ndt\/gfab333","article-title":"Inflammation and physical dysfunction: responses to moderate intensity exercise in chronic kidney disease","volume":"37","author":"Watson","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2026.02.009_bib0022","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1681\/ASN.2013070702","article-title":"Evidence for anti-inflammatory effects of exercise in CKD","volume":"25","author":"Viana","year":"2014","journal-title":"J Am Soc Nephrol JASN"},{"key":"10.1016\/j.trsl.2026.02.009_bib0023","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jcsm.12802","article-title":"Primary skeletal muscle cells from chronic kidney disease patients retain hallmarks of cachexia in vitro","volume":"13","author":"Baker","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.trsl.2026.02.009_bib0024","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014713","article-title":"Physical activity, immune function and inflammation in kidney patients (the PINK study): a feasibility trial protocol","volume":"7","author":"Highton","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.trsl.2026.02.009_bib0025","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/hex.13225","article-title":"Determinants of patient activation and its association with cardiovascular disease risk in chronic kidney disease: a cross-sectional study","volume":"24","author":"Wilkinson","year":"2021","journal-title":"Health Expect"},{"key":"10.1016\/j.trsl.2026.02.009_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-046945","article-title":"A pilot randomised controlled trial of a structured, home-based exercise programme on cardiovascular structure and function in kidney transplant recipients: the ECSERT study design and methods","volume":"11","author":"Billany","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.trsl.2026.02.009_bib0027","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12882-016-0294-7","article-title":"Design and methods of CYCLE-HD: improving cardiovascular health in patients with end stage renal disease using a structured programme of exercise: a randomised control trial","volume":"17","author":"Graham-Brown","year":"2016","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.trsl.2026.02.009_bib0028","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/j.jrn.2021.06.005","article-title":"A systematic review of handgrip strength measurement in clinical and epidemiological studies of kidney disease: toward a standardized approach","volume":"32","author":"Wilkinson","year":"2022","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.trsl.2026.02.009_bib0029","doi-asserted-by":"crossref","DOI":"10.1177\/01617346241255879","article-title":"Skeletal muscle texture assessment using ultrasonography: comparison with magnetic resonance imaging in chronic kidney disease","author":"Wilkinson","year":"2024","journal-title":"Ultrason Imaging"},{"key":"10.1016\/j.trsl.2026.02.009_bib0030","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1096\/fj.201901936RR","article-title":"Reductions in skeletal muscle mitochondrial mass are not restored following exercise training in patients with chronic kidney disease","volume":"34","author":"Watson","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2026.02.009_bib0031","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/01617346211009788","article-title":"Quantitative muscle ultrasonography using 2D textural analysis: a novel approach to assess skeletal muscle structure and quality in chronic kidney disease","volume":"43","author":"Wilkinson","year":"2021","journal-title":"Ultrason Imaging"},{"key":"10.1016\/j.trsl.2026.02.009_bib0032","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150112","article-title":"Muscle fibrosis and maladaptation occur progressively in CKD and are rescued by dialysis","volume":"6","author":"Brightwell","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2026.02.009_bib0033","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.freeradbiomed.2015.12.031","article-title":"The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass","volume":"98","author":"Rom","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.trsl.2026.02.009_bib0034","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.trsl.2026.02.009_bib0035","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afae052","article-title":"The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS)","volume":"53","author":"Kirk","year":"2024","journal-title":"Age Ageing"},{"key":"10.1016\/j.trsl.2026.02.009_bib0036","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/jcsm.12202","article-title":"Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction: therapy for CKD-associated muscle dysfunction","volume":"8","author":"Enoki","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.trsl.2026.02.009_bib0037","doi-asserted-by":"crossref","first-page":"F1658","DOI":"10.1152\/ajprenal.00314.2018","article-title":"Skeletal muscle fibrosis is associated with decreased muscle inflammation and weakness in patients with chronic kidney disease","volume":"315","author":"Abramowitz","year":"2018","journal-title":"Am J Physiol-Ren Physiol"},{"key":"10.1016\/j.trsl.2026.02.009_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111594","article-title":"Quantity versus quality: age-related differences in muscle volume, intramuscular fat, and mechanical properties in the triceps surae","volume":"156","author":"Pinel","year":"2021","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.trsl.2026.02.009_bib0039","first-page":"1344","article-title":"Quality over quantity? Association of skeletal muscle myosteatosis and myofibrosis on physical function in chronic kidney disease","volume":"34","author":"Wilkinson","year":"2019","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"10.1016\/j.trsl.2026.02.009_bib0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/jcsm.12129","article-title":"Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease: toll-like receptor 4 in muscle of chronic kidney disease patients","volume":"8","author":"Verzola","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.trsl.2026.02.009_bib0041","first-page":"1","article-title":"Therapeutic approaches in mitochondrial dysfunction, inflammation, and autophagy in uremic cachexia: role of aerobic exercise","volume":"2019","author":"Zhang","year":"2019","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.trsl.2026.02.009_bib0042","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/aps.2013.198","article-title":"Chemerin C9 peptide induces receptor internalization through a clathrin-independent pathway","volume":"35","author":"Zhou","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.trsl.2026.02.009_bib0043","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1002\/jcb.26807","article-title":"Resolvin E1 (RvE1) attenuates LPS induced inflammation and subsequent atrophy in C2C12 myotubes","volume":"119","author":"Baker","year":"2018","journal-title":"J Cell Biochem"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426000472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426000472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:04:56Z","timestamp":1777622696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524426000472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":43,"alternative-id":["S1931524426000472"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2026.02.009","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the role of chemerin in skeletal muscle phenotype in those with kidney disease","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2026.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}